132 related articles for article (PubMed ID: 31517774)
61. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
Feng W; Hua K; Malpica A; Zhou X; Baak JP
Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
[TBL] [Abstract][Full Text] [Related]
62. Uterine Sarcomas: The Latest Approaches for These Rare but Potentially Deadly Tumors.
Chern JY; Boyd LR; Blank SV
Oncology (Williston Park); 2017 Mar; 31(3):229-36. PubMed ID: 28299760
[TBL] [Abstract][Full Text] [Related]
63. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
64. Treatment of patients with sarcoma of the uterus.
Bokhman JV; Yakovleva IA; Urmanchejeva AF
Eur J Gynaecol Oncol; 1990; 11(3):225-31. PubMed ID: 2209643
[TBL] [Abstract][Full Text] [Related]
65. Prognostic factors associated with uterine sarcomas: the experience of a single institution.
Barquet-Muñoz SA; Isla-Ortiz D; Montalvo-Esquivel G; Cantú-de-León D; Salcedo-Hernández RA; Cordoba-Gonzalez V; Herrera-Gómez Á
J Obstet Gynaecol; 2019 Feb; 39(2):231-236. PubMed ID: 30354797
[TBL] [Abstract][Full Text] [Related]
66. Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study.
Major FJ; Blessing JA; Silverberg SG; Morrow CP; Creasman WT; Currie JL; Yordan E; Brady MF
Cancer; 1993 Feb; 71(4 Suppl):1702-9. PubMed ID: 8381710
[TBL] [Abstract][Full Text] [Related]
67. Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945-1980.
De Fusco PA; Gaffey TA; Malkasian GD; Long HJ; Cha SS
Gynecol Oncol; 1989 Oct; 35(1):8-14. PubMed ID: 2792908
[TBL] [Abstract][Full Text] [Related]
68. Uterine sarcoma.
Belgrad R; Elbadawi N; Rubin P
Radiology; 1975 Jan; 114(1):181-8. PubMed ID: 1208858
[TBL] [Abstract][Full Text] [Related]
69. The role of adjuvant radiation in uterine sarcomas.
Sampath S; Schultheiss TE; Ryu JK; Wong JY
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):728-34. PubMed ID: 19700247
[TBL] [Abstract][Full Text] [Related]
70. Prognostic features of sarcomas and mixed tumors of the endometrium.
Peters WA; Kumar NB; Fleming WP; Morley GW
Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081
[TBL] [Abstract][Full Text] [Related]
71. Uterine sarcomas.
Punnonen R; Lauslahti K; Pystynen P; Kauppila O
Ann Chir Gynaecol Suppl; 1985; 197():11-4. PubMed ID: 3863523
[TBL] [Abstract][Full Text] [Related]
72. Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients.
Moskovic E; MacSweeney E; Law M; Price A
Br J Radiol; 1993 Nov; 66(791):1009-15. PubMed ID: 8281375
[TBL] [Abstract][Full Text] [Related]
73. Uterine sarcoma: an analysis of 74 cases.
Covens AL; Nisker JA; Chapman WB; Allen HH
Am J Obstet Gynecol; 1987 Feb; 156(2):370-4. PubMed ID: 3030107
[TBL] [Abstract][Full Text] [Related]
74. Prognostic factors and outcome in women with uterine sarcoma.
Denschlag D; Masoud I; Stanimir G; Gilbert L
Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
[TBL] [Abstract][Full Text] [Related]
75. Treatment of uterine sarcomas.
Echt G; Jepson J; Steel J; Langholz B; Luxton G; Hernandez W; Astrahan M; Petrovich Z
Cancer; 1990 Jul; 66(1):35-9. PubMed ID: 2354406
[TBL] [Abstract][Full Text] [Related]
76. [Prognostic factors in uterine sarcomas: a 21-year retrospective study at the Clinic and Provincial Hospital of Barcelona].
Rovirosa A; Ordi J; Ascaso C; Casals J; Lejarcegui A; Iglesias J; Estapé J; Biete A
Med Clin (Barc); 1998 Jul; 111(5):172-6. PubMed ID: 9732833
[TBL] [Abstract][Full Text] [Related]
77. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases.
Chang KL; Crabtree GS; Lim-Tan SK; Kempson RL; Hendrickson MR
Am J Surg Pathol; 1990 May; 14(5):415-38. PubMed ID: 2327549
[TBL] [Abstract][Full Text] [Related]
78. Update on treatment of uterine sarcoma.
Nam JH; Park JY
Curr Opin Obstet Gynecol; 2010 Feb; 22(1):36-42. PubMed ID: 19923988
[TBL] [Abstract][Full Text] [Related]
79. Efficacy of Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Treatment of Recurrent Uterine Sarcoma.
Díaz-Montes TP; El-Sharkawy F; Lynam S; Harper A; Sittig M; MacDonald R; Gushchin V; Sardi A
Int J Gynecol Cancer; 2018 Jul; 28(6):1130-1137. PubMed ID: 29975291
[TBL] [Abstract][Full Text] [Related]
80. Uterine sarcomas: a clinicopathologic study, 1965-1981.
Marchese MJ; Liskow AS; Crum CP; McCaffrey RM; Frick HC
Gynecol Oncol; 1984 Jul; 18(3):299-312. PubMed ID: 6086468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
